95 filings
Page 2 of 5
6-K
nfos0y8xc64b7ink2t4
16 May 23
ERYTECH Provides Update on the Announced Combination with PHERECYDES
10:14am
6-K
9fmonl ujj
10 May 23
ERYTECH Provides Business and Financial Update for the First Quarter of 2023
8:55am
6-K
1iz3p
18 Apr 23
ERYTECH Announces Approval to Transfer its Listing to the Nasdaq Capital Market
8:20am
6-K
k2upuo0l5r6toryum4
23 Mar 23
ERYTECH Provides Business and Financial Update for the Fourth Quarter and Full Year 2022
9:37am
6-K
5k15qb
16 Feb 23
This press release does not constitute an offer to purchase any securities
4:25pm
6-K
k26hx3ffhl ecosb3
22 Nov 22
ERYTECH Provides Business and Financial Update for the Third Quarter of 2022
11:08am
6-K
ndwx1ghnqcu4ordtbcq9
14 Oct 22
ERYTECH Announces Receipt of Nasdaq Notice
6:11am
6-K/A
l3n psiu6f5
12 Sep 22
I.Certification of the Person Responsible for the Half-year Financial Report
4:33pm
6-K
rmkiqn2oo 3a4h
12 Sep 22
I.Certification of the Person Responsible for the Half-year Financial Report
12:04pm
6-K
sp2zanwp9 3jqo1sm8
25 Aug 22
ERYTECH Provides Regulatory Update
10:13am
6-K
8qvs 8kt8c67qlu54
28 Jun 22
Current report (foreign)
9:01am
6-K
osqrdi23veo8 3ofr
25 May 22
Current report (foreign)
8:11am
6-K
419wzhw46h nk10
13 May 22
ERYTECH Provides Business and Financial Update for the First Quarter of 2022
11:37am
6-K
vc7i3 7syg75u
2 May 22
ERYTECH Announces Filing of 2021 Universal Registration Document and 2021 Annual Report on Form 20-F, as well as its 2022 financial calendar
9:47am
6-K
2jvvx3dfhypgjoo9m4t3
28 Apr 22
Asset Purchase Agreement
8:30am
6-K
alkpa
25 Apr 22
Current report (foreign)
4:31pm
6-K
spia6l
15 Mar 22
ERYTECH Provides Business and Financial Update for the Fourth Quarter and Full Year 2021
9:19am
6-K
uximap
10 Feb 22
ERYTECH Expands Patent Portfolio for the Treatment of Rare Metabolic Diseases
8:19am
6-K
xq5167vqs16x
27 Jan 22
ERYTECH Announces Presentation of
1:20pm
6-K
prwaq28 f9r3jbowszl
16 Dec 21
Erytech Announces Presentation of Results of Expanded Access Program In All at 2021 Ash Annual Meeting and Acceptance of Two Abstracts at Asco Gi
5:23pm